About Scientia Investigacion Clinica S.C.
Clinical Trials at Scientia Investigacion Clinica S.C.
During the past decade, Scientia Investigacion Clinica S.C. conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 4 clinical trials were completed, i.e. on
average, 26.7% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 4 clinical trials were completed. i.e. 33.3%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Scientia Investigacion Clinica S.C." #1 sponsor was "Eli Lilly and Company" with 8 trials, followed by "Amgen" with 2 trials
sponsored, "Arena Pharmaceuticals" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Hoffmann-La Roche"
with 2 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Scientia Investigacion Clinica S.C."
#1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator and "Dermira, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Scientia Investigacion Clinica S.C.
According to Clinical.Site data, the most researched conditions in "Scientia Investigacion Clinica S.C." are
"Ulcerative Colitis" (6 trials), "Crohn's Disease" (3 trials), "Abiraterone Acetate" (1 trials), "Androgens" (1 trials) and "Antineoplastic Agents" (1 trials). Many other conditions were trialed in "Scientia Investigacion Clinica S.C." in a lesser frequency.
Clinical Trials Intervention Types at Scientia Investigacion Clinica S.C.
Most popular intervention types in "Scientia Investigacion Clinica S.C." are "Drug" (14 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (8 trials), "Etrasimod" (4 trials), "Mirikizumab" (4 trials), "Abemaciclib" (1 trials) and "Abiraterone" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Scientia Investigacion Clinica S.C.
The vast majority of trials in "Scientia Investigacion Clinica S.C." are
14 trials for "All" genders and 1 trials for "Male" genders.
Clinical Trials Status at Scientia Investigacion Clinica S.C.
Currently, there are NaN active trials in "Scientia Investigacion Clinica S.C.".
undefined are not yet recruiting,
10 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Scientia Investigacion Clinica S.C.,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Scientia Investigacion Clinica S.C., 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 14 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".